Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Active, not recruiting · NCT06256432 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome | Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, acute kidney injury, cirrhosis of liver, hepatorenal syndrome, kidney disorder, kidney failure, liver disorder, urinary system disorder | Active, not recruiting | Phase 2 | 2026-04-13 | NCT06256432 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Noorik Biopharmaceuticals AG | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| All India Institute Of Medical Sciences | New Delhi | India | 14 |
| Asian Institute of Gastroenterology (AIG) | Hyderabad | India | 1 |
| Aster CMI Hospital | Bangalore | India | 2 |
| Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College | Kanpur | India | 1 |
| Medanta Multi Super Specialty Hospital | Lucknow | India | 1 |
| Sir HN Reliance Hospital Foundation | Mumbai | India | 1 |